The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9303033, O2, Example 27 ID: ALA3985598
PubChem CID: 136398152
Max Phase: Preclinical
Molecular Formula: C18H21N7O2
Molecular Weight: 367.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1NC(=O)/C(=C/c2cnn3c(NC4CC4)cc(NC4CCCC4)nc23)N1
Standard InChI: InChI=1S/C18H21N7O2/c26-17-13(22-18(27)24-17)7-10-9-19-25-15(21-12-5-6-12)8-14(23-16(10)25)20-11-3-1-2-4-11/h7-9,11-12,21H,1-6H2,(H,20,23)(H2,22,24,26,27)/b13-7-
Standard InChI Key: NBQJLSZPMCVDJI-QPEQYQDCSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
2.1760 -8.1488 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2028 -7.4466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2222 -7.9149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1079 -6.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3079 -6.7011 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2234 -5.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6890 -4.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3408 4.2142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8408 4.2089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2526 1.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2524 0.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4979 -1.0529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0317 -0.7359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1979 -5.9466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
4 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 14 1 0
12 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
18 25 2 0
25 26 1 0
26 8 2 0
26 11 1 0
6 27 1 0
27 2 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.41Molecular Weight (Monoisotopic): 367.1757AlogP: 1.84#Rotatable Bonds: 5Polar Surface Area: 112.45Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.24CX Basic pKa: 3.97CX LogP: 0.81CX LogD: 0.43Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.47Np Likeness Score: -0.98
References 1. (2016) Pyrazolopyrimidines and related heterocycles as CK2 inhibitors,